Compare TGL & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGL | PRFX |
|---|---|---|
| Founded | 2020 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.6M |
| IPO Year | 2022 | 2020 |
| Metric | TGL | PRFX |
|---|---|---|
| Price | $3.57 | $0.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 58.1K |
| Earning Date | 12-01-2026 | 09-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.53 | N/A |
| EPS | ★ 16.03 | N/A |
| Revenue | ★ $5,169,784.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 121.83 | N/A |
| 52 Week Low | $0.14 | $0.58 |
| 52 Week High | $587.80 | $5.39 |
| Indicator | TGL | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 81.19 | 38.47 |
| Support Level | $2.59 | $0.67 |
| Resistance Level | $4.27 | $1.25 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | 0.42 | -0.00 |
| Stochastic Oscillator | 75.82 | 11.91 |
Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, a digital rewards and lifestyle platform based in Malaysia that uses artificial intelligence to offer personalized shopping deals, discounts, and rebates, and targets consumers by providing personalized deals based on their purchase history, location, and preferences. The company has two reportable segments: the ZCITY platform, which generates the maximum revenue, and Customized software development service.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.